Madrigalpharma

About Madrigalpharma

Madrigalpharma is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is the first and only FDA and European Commission approved treatment for MASH with moderate to advanced fibrosis.

Career Opportunities

Madrigalpharma offers a dynamic and inclusive work environment that values scientific excellence and operational rigor. The company is committed to professional growth and ensuring that the right talent is in place to support its mission.

• Dynamic and inclusive culture
• Focus on scientific excellence
• Commitment to professional growth